Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Indorama Ventures Oxides LLC has 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 3 distinct examiners, indicating that each matter is handled by a different individual. This arrangement ensures a variety of perspectives on the portfolio's current filings. The use of multiple examiners can help mitigate the risk of a single unfavorable interpretation affecting the entire portfolio.
ALI S SAEED is the busiest examiner for the portfolio, handling 1 pending office action. The 3 pending office actions are spread across 2 distinct art units, meaning there is some departmental concentration. For the company, this means that while they must manage different examiner relationships, they may encounter consistent trends within the 2 distinct art units. This departmental focus can be leveraged by practitioners to develop a more cohesive strategy for the 3 pending office actions.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 3 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SAEED, ALI S | 1 | 32.6% | +35.4% |
| BAHTA, MEDHANIT W | 1 | 80.5% | +27.8% |
| LIU, SUE XU | 1 | 20.9% | +18.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16009702 | METHOD OF PREPARING AMIDOAMINE ALKOXYLATES AND COMPOSITIONS THEREOF | LIU, SUE XU | 55d |
| 18935034 | Maleated Natural Oil Derivatives As Agrochemical Inert Ingredients | SAEED, ALI S | — |
| 18691377 | ALKOXYLATION OF CANNABIDIOL AND OTHER CANNABINOIDS | BAHTA, MEDHANIT W | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16009702 | METHOD OF PREPARING AMIDOAMINE ALKOXYLATES AND COMPOSITIONS THEREOF | LIU, SUE XU | 55d |
| 18935034 | Maleated Natural Oil Derivatives As Agrochemical Inert Ingredients | SAEED, ALI S | — |
| 18691377 | ALKOXYLATION OF CANNABIDIOL AND OTHER CANNABINOIDS | BAHTA, MEDHANIT W | — |
| Art Unit | Apps |
|---|---|
| 1616 | 2 |
| 1692 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18935034 | Maleated Natural Oil Derivatives As Agrochemical Inert Ingredients | SAEED, ALI S | 1616 | §103§112 | Non-Final OA | — | Pending | Nov 01, 2024 |
| 18691377 | ALKOXYLATION OF CANNABIDIOL AND OTHER CANNABINOIDS | BAHTA, MEDHANIT W | 1692 | §103§112 | Non-Final OA | — | Pending | Mar 12, 2024 |
| 16009702 | METHOD OF PREPARING AMIDOAMINE ALKOXYLATES AND COMPOSITIONS THEREOF | LIU, SUE XU | 1616 | §103§112 | Non-Final OA | 55d | Pending | Jun 15, 2018 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialIndorama Ventures Oxides LLC has 3 pending office actions as of November 2026, spread across 2 art units and 3 examiners.
Ali S Saeed has the most, with 1 of Indorama Ventures Oxides LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.